newsfilter
← Latest News
Business Wire·

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers,